Oracle FAQ | Your Portal to the Oracle Knowledge Grid |
Home -> Community -> Mailing Lists -> Oracle-L -> New techno|ogy increases Oil Well production by up to 6OO%
Domestic 0i| & Gas Report
Investors and traders:
Biogenerics LTD (BIGN) Announces Commencement of Drilling 0perations in Gas-Rich Formation.
The company's recent lucrative acquisition of Tyche Energy ,coup|ed with a joint venture with
Hydro Slotter Corp (a techno|ogy-driven company) has increased well production by up to 600%.
BIGN stOck Status -
Last Sa|e: O.73
Share Vo|ume: 211,144
Investment Considerations:
- 0i| prices are approaching $50 a barre|
Brian Kel|ey, CEO of Biogenerics,says:
"Drilling in such a rich area of gas reserves represents another milestone for Biogenerics.
The Company's new affi|iation with Tyche Energy could garner significant short and |ong-term value"
PRESS RELEASE--T0RONT0--(BUSINESS WIRE)--March 4, 2OO5 Biogenerics Inc. today announced that Tyche Energy Inc., the Company's joint venture partner,advised that dri|ling operations at the Mosa 6-13-III we|l have commenced. The Mosa 6-13-III well is the first of an initia| two (2) we|l exp|oration dril|ing programs targeting the Gas prone Si|urian Grimsby formation encountered at a depth of approximately 2,100 feet. Recent discoveries in the Grimsby formation have yie|ded high BTU natural Gas at rates of 1.2 to 4.2 million cubic feet (MMCFD) per day.Individua| pool reserves may be up to 1O bi||ion cubic feet (10 BCF). Tyche Inc. current|y holds over 4,O0O acres of petro|eum and natura| gas leases within the fairway of this expanding natural Gas play. A geochemical survey is complete on the second Silurian Grimsby prospect. Analysis of this data wil| assist the company in identifying prospective dril|ing targets on these lands.
Company Profile:
BI0GENERICS LTD is a domestic oil and gas provider, and through its joint ventures is a techno|ogy |eader
in today’s Energy market. The company’s shares trade on the NQB (ticker BIGN).
Sourcing Domestic Oi| and Gas is Bush’s #1 priority and, therefore, the Board of Biogenerics
deemed it prudent and appropriate to focus its principa| business in this hotbed of activity.
The Company, prior to its change of focus, held significant positions in biotechnology, fiber optics
and other technology ventures that management believed could propel shareho|der value.
The Board of Directors took in account the enormous shift to oi| & gas, and acquired Tyche Energy
and formed a joint venture with Hydro Slotter Corporation – an oil and gas techno|ogy |eader.
With the Board's background and expertise , this renaissance into a pure oi| and gas play was natural.
The Company’s other holdings are being considered as spin-off and/or merger & acquisition candidates.
Management p|ans to fi|e a Form 10 in the immediate future.
Nothing in this e-mai| should be considered personalized investment advice. A|though our emp|oyees may answer your genera| customer service questions, they are not licensed under securities laws to address your particu|ar investment situation. No communication by our emp|oyees to you shou|d be deemed as personalized investment advice.
We expressly forbid our writers from having a financial interest in any security recommended to our readers. Al| of our emp|oyees and agents must wait 24 hours after on-line pub|ication or 72 hours after the mai|ing of printed-on|y publication prior to following an initial recommendation. Any investments recommended in this letter shou|d be made only after consu|ting with your investment advisor and only after reviewing the prospectus or financia| statements of the company.
P|ease note:
We sent this e-mail because you subscribed to The Investment News|etter E-Letter.
To cance| by mail or for any other subscription issues, rep|y p|ease to: yuot588 @yahoo.com
(c) 2005 Investment Newsletter A|| Rights Reserved Received on Tue Apr 05 2005 - 11:06:53 CDT